Museum Prescription by a Physician for a Visit to the MBAM
PM
1 other identifier
interventional
86
1 country
1
Brief Summary
In recent years, museums have participated in the patient care journey by using art to enhance their quality of life and well-being. Since 2015, the Montreal Museum of Fine Arts (MMFA) and Dr. Beauchet have developed an Action-Research program exploring the effects of participatory art activities for community elders conducted at the MMFA, known as the Arts \& Longevity Lab (ALL). The mandate of ALL is to improve the well-being, quality of life and health (i.e. mental and physical state) of individuals and patients through the practice of visual arts activities (i.e. arts that produce objects perceived by the eyes). Since 2019, the MMFA has developed in collaboration with Médecins Francophones du Canada museum visits prescribed by a primary care physician as a new intervention. Today, it is necessary to improve the knowledge on the effects of this museum visit prescription The overall objective of this study is to examine the effects of a visit to the MMFA prescribed by a primary care physician on the mental health (well-being and quality of life) of patients living in Montreal.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable quality-of-life
Started Jun 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 27, 2022
CompletedFirst Submitted
Initial submission to the registry
June 30, 2022
CompletedFirst Posted
Study publicly available on registry
July 6, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 21, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2023
CompletedFebruary 23, 2024
February 1, 2024
1.1 years
June 30, 2022
February 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Quality of life
Quality of life will be assessed using the EuroQol-5D (EQ-5D). EuroQol-5D is composed of two parts: * a five-question questionnaire with a score per question ranging from 1 (no problem) to 5 (severe problem), so that the sum ranged from 0 (no problem) to 25 (severe problem). * a visual analogue scale on participants' perceived health. This scale is numbered from 0 (i.e., the worst health the participant can imagine) to 100 (i.e., the best health the participant can imagine). This questionnaire will be completed online on the CRIUGM web platform using an electronic device.
3 months
Well-being
Well-being will be assessed using the Warwick-Edinburgh Mental Well-being Scale (WEMWBS). The WEMWBS is a validated questionnaire composed by a 14-item positively worded scale and five response categories. It covers most aspects of positive mental health (positive thoughts and feelings). This questionnaire will be completed online on the CRIUGM web platform using an electronic device.
3 months
Secondary Outcomes (4)
Physical Health Status
3 months
Social Isolation
3 months
Prescribing context
3 months
Satisfaction from the visit to the museum
3 months
Study Arms (1)
Intervention
EXPERIMENTALPhysicians participating in the research project will be able to prescribe a visit to the Museum to any of their patients for whom they deem this museum prescription necessary. Only patients who meet the inclusion criteria will be offered to participate in the research. If patients refuse or do not meet the inclusion criteria, they may be prescribed a museum visit but will not be offered the study. After obtaining informed consent, the patient will be asked to complete 2 sets of self-administered questionnaires: in the 2 days prior to the visit and in the 2 days following the MBAM visit.
Interventions
The intervention is a visit of the MMFA. This visit can be done alone or accompanied. The visit of the MMFA is free for the patient.
Eligibility Criteria
You may qualify if:
- age 18 and over
- having Internet access at home with an electronic device (computer, keyboard, or smartphone)
- having no dementia
- speaking English or French
- committing to visiting the museum within 3 months of the prescription.
You may not qualify if:
- individuals participating in a clinical trial at the same time, to avoid interference with the results of the intervention being studied in this protocol
- individuals with dementia. There are no tests for dementia. The physicians involved in the pre-recruitment process are aware of the cognitive status of their patients. Therefore, they will be able to avoid offering the study to a patient with dementia if such a diagnosis appears in the medical file.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CRIUGM
Montreal, Quebec, H3W 1W5, Canada
Related Publications (1)
Beauchet O, Moret A, Deveault M, Thiboutot C, Parent N, Boyer H, Galery K. Physician-prescribed museum visit benefits on mental health: results of an experimental study. Front Med (Lausanne). 2025 May 14;12:1590145. doi: 10.3389/fmed.2025.1590145. eCollection 2025.
PMID: 40438362DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD, Senior researcher, Director of laboratory
Study Record Dates
First Submitted
June 30, 2022
First Posted
July 6, 2022
Study Start
June 27, 2022
Primary Completion
July 21, 2023
Study Completion
December 22, 2023
Last Updated
February 23, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share